A010600 Stock Overview
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Wellbiotec Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩545.00 |
| 52 Week High | ₩5,200.00 |
| 52 Week Low | ₩519.00 |
| Beta | 1.24 |
| 1 Month Change | -38.97% |
| 3 Month Change | -46.41% |
| 1 Year Change | -64.95% |
| 3 Year Change | -86.72% |
| 5 Year Change | -85.25% |
| Change since IPO | -96.88% |
Recent News & Updates
Shareholder Returns
| A010600 | KR Luxury | KR Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -4.3% |
| 1Y | -65.0% | -24.2% | -1.0% |
Return vs Industry: A010600 underperformed the KR Luxury industry which returned -24.2% over the past year.
Return vs Market: A010600 underperformed the KR Market which returned -1% over the past year.
Price Volatility
| A010600 volatility | |
|---|---|
| A010600 Average Weekly Movement | 14.6% |
| Luxury Industry Average Movement | 4.1% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A010600's share price has been volatile over the past 3 months.
Volatility Over Time: A010600's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 29 | Dong-Hyun Song | www.wellbiotec.com |
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and specialized medicines, health functional foods, protection products, diagnosis kits, cosmeceuticals, and other products.
Wellbiotec Co., Ltd. Fundamentals Summary
| A010600 fundamental statistics | |
|---|---|
| Market cap | ₩49.55b |
| Earnings (TTM) | -₩64.91b |
| Revenue (TTM) | ₩72.13b |
0.7x
P/S Ratio-0.8x
P/E RatioIs A010600 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A010600 income statement (TTM) | |
|---|---|
| Revenue | ₩72.13b |
| Cost of Revenue | ₩62.19b |
| Gross Profit | ₩9.94b |
| Other Expenses | ₩74.85b |
| Earnings | -₩64.91b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -713.91 |
| Gross Margin | 13.78% |
| Net Profit Margin | -89.99% |
| Debt/Equity Ratio | 15.0% |
How did A010600 perform over the long term?
See historical performance and comparison